Literature DB >> 28663439

A cyclic oligonucleotide signaling pathway in type III CRISPR-Cas systems.

Migle Kazlauskiene1, Georgij Kostiuk1, Česlovas Venclovas1, Gintautas Tamulaitis2, Virginijus Siksnys2.   

Abstract

Type III CRISPR-Cas systems in prokaryotes provide immunity against invading nucleic acids through the coordinated degradation of transcriptionally active DNA and its transcripts by the Csm effector complex. The Cas10 subunit of the complex contains an HD nuclease domain that is responsible for DNA degradation and two Palm domains with elusive functions. In addition, Csm6, a ribonuclease that is not part of the complex, is also required to provide full immunity. We show here that target RNA binding by the Csm effector complex of Streptococcus thermophilus triggers Cas10 to synthesize cyclic oligoadenylates (cA n ; n = 2 to 6) by means of the Palm domains. Acting as signaling molecules, cyclic oligoadenylates bind Csm6 to activate its nonspecific RNA degradation. This cyclic oligoadenylate-based signaling pathway coordinates different components of CRISPR-Cas to prevent phage infection and propagation.
Copyright © 2017 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28663439     DOI: 10.1126/science.aao0100

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  125 in total

1.  Structure Studies of the CRISPR-Csm Complex Reveal Mechanism of Co-transcriptional Interference.

Authors:  Lilan You; Jun Ma; Jiuyu Wang; Daria Artamonova; Min Wang; Liang Liu; Hua Xiang; Konstantin Severinov; Xinzheng Zhang; Yanli Wang
Journal:  Cell       Date:  2018-11-29       Impact factor: 41.582

2.  Dynamics of Cas10 Govern Discrimination between Self and Non-self in Type III CRISPR-Cas Immunity.

Authors:  Ling Wang; Charlie Y Mo; Michael R Wasserman; Jakob T Rostøl; Luciano A Marraffini; Shixin Liu
Journal:  Mol Cell       Date:  2018-11-29       Impact factor: 17.970

3.  Nucleic Acid Detection of Plant Genes Using CRISPR-Cas13.

Authors:  Omar O Abudayyeh; Jonathan S Gootenberg; Max J Kellner; Feng Zhang
Journal:  CRISPR J       Date:  2019-06

4.  Tolerance of Sulfolobus SMV1 virus to the immunity of I-A and III-B CRISPR-Cas systems in Sulfolobus islandicus.

Authors:  Tong Guo; Wenyuan Han; Qunxin She
Journal:  RNA Biol       Date:  2018-07-09       Impact factor: 4.652

5.  Characterization of a novel type III CRISPR-Cas effector provides new insights into the allosteric activation and suppression of the Cas10 DNase.

Authors:  Jinzhong Lin; Mingxia Feng; Heping Zhang; Qunxin She
Journal:  Cell Discov       Date:  2020-05-12       Impact factor: 10.849

6.  Second Messenger cA4 Formation within the Composite Csm1 Palm Pocket of Type III-A CRISPR-Cas Csm Complex and Its Release Path.

Authors:  Ning Jia; Roger Jones; George Sukenick; Dinshaw J Patel
Journal:  Mol Cell       Date:  2019-07-17       Impact factor: 17.970

7.  Evolutionary and functional classification of the CARF domain superfamily, key sensors in prokaryotic antivirus defense.

Authors:  Kira S Makarova; Albertas Timinskas; Yuri I Wolf; Ayal B Gussow; Virginijus Siksnys; Česlovas Venclovas; Eugene V Koonin
Journal:  Nucleic Acids Res       Date:  2020-09-18       Impact factor: 16.971

8.  Identification of Uncharacterized Components of Prokaryotic Immune Systems and Their Diverse Eukaryotic Reformulations.

Authors:  A Maxwell Burroughs; L Aravind
Journal:  J Bacteriol       Date:  2020-11-19       Impact factor: 3.490

9.  Cyclic di-AMP, a second messenger of primary importance: tertiary structures and binding mechanisms.

Authors:  Jin He; Wen Yin; Michael Y Galperin; Shan-Ho Chou
Journal:  Nucleic Acids Res       Date:  2020-04-06       Impact factor: 16.971

10.  Diversity and classification of cyclic-oligonucleotide-based anti-phage signalling systems.

Authors:  Adi Millman; Sarah Melamed; Gil Amitai; Rotem Sorek
Journal:  Nat Microbiol       Date:  2020-08-24       Impact factor: 17.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.